Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BG00012

oral

DRUG

BG00012

Oral

DRUG

placebo

oral placebo

Trial Locations (24)

4102

Research Site, Woolloongabba

5011

Research Site, Woodville

N7T4X3

Research Site, Sarnia

Unknown

Research Site, New Market

Research Site, Ottawa

Research Site, Rothesay

Research Site, Active, Not Recruiting

Research Site, Pardubice

Research Site, Uh. Hradiste

Research Site, Zlín

Research Site, Bangalore

Research Site, Hyderabaad

Research Site, Hyderabad

Research Site, Lucknow

Research Site, Bialystock

Research Site, Grodzisk Mazowiecki

Research Site, Lublin

Research Site, Poznan

Research Site, Torun

Research Site, Warsaw

Research Site, Banska Bysterica

Research Site, Bratislava

Research Site, Košice

Research Site, Piešťany

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00810836 - Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter